224 related articles for article (PubMed ID: 18181000)
1. An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection.
Hernandez J; Cowgill SM; Al-Saadi S; Villadolid D; Ross S; Kraemer E; Shapiro M; Mullinax J; Cooper J; Goldin S; Zervos E; Rosemurgy A
Ann Surg Oncol; 2008 Mar; 15(3):807-14. PubMed ID: 18181000
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
[TBL] [Abstract][Full Text] [Related]
3. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
[TBL] [Abstract][Full Text] [Related]
4. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy.
Serafini FM; Sachs D; Bloomston M; Carey LC; Karl RC; Murr MM; Rosemurgy AS
Am Surg; 2001 Sep; 67(9):839-43; discussion 843-4. PubMed ID: 11565760
[TBL] [Abstract][Full Text] [Related]
5. In-continuity hepatic resection for advanced hilar cholangiocarcinoma.
Zervos EE; Pearson H; Durkin AJ; Thometz D; Rosemurgy P; Kelley S; Rosemurgy AS
Am J Surg; 2004 Nov; 188(5):584-8. PubMed ID: 15546575
[TBL] [Abstract][Full Text] [Related]
6. A single center experience with extrahepatic cholangiocarcinomas.
Johnson SR; Kelly BS; Pennington LJ; Hanto DW
Surgery; 2001 Oct; 130(4):584-90; discussion 590-2. PubMed ID: 11602888
[TBL] [Abstract][Full Text] [Related]
7. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
[TBL] [Abstract][Full Text] [Related]
8. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.
Ribero D; Amisano M; Lo Tesoriere R; Rosso S; Ferrero A; Capussotti L
Ann Surg; 2011 Nov; 254(5):776-81; discussion 781-3. PubMed ID: 22042470
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
10. Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins.
Hernandez J; Mullinax J; Clark W; Toomey P; Villadolid D; Morton C; Ross S; Rosemurgy A
Ann Surg; 2009 Jul; 250(1):76-80. PubMed ID: 19561479
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma.
Konishi M; Iwasaki M; Ochiai A; Hasebe T; Ojima H; Yanagisawa A
Br J Surg; 2010 Sep; 97(9):1363-8. PubMed ID: 20632323
[TBL] [Abstract][Full Text] [Related]
12. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma.
Shingu Y; Ebata T; Nishio H; Igami T; Shimoyama Y; Nagino M
Surgery; 2010 Jan; 147(1):49-56. PubMed ID: 19767048
[TBL] [Abstract][Full Text] [Related]
15. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases.
Ikeyama T; Nagino M; Oda K; Ebata T; Nishio H; Nimura Y
Ann Surg; 2007 Dec; 246(6):1052-7. PubMed ID: 18043110
[TBL] [Abstract][Full Text] [Related]
16. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.
Konstadoulakis MM; Roayaie S; Gomatos IP; Labow D; Fiel MI; Miller CM; Schwartz ME
Am J Surg; 2008 Aug; 196(2):160-9. PubMed ID: 18466862
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
[TBL] [Abstract][Full Text] [Related]
18. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
[TBL] [Abstract][Full Text] [Related]
19. Aggressive surgical resection for hilar cholangiocarcinoma.
Lai EC; Lau WY
ANZ J Surg; 2005 Nov; 75(11):981-5. PubMed ID: 16336393
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
